Tag Archives: Ipsen

October, 2017

June, 2017

January, 2017

  • 9 January

    Ipsen to Acquire Oncology Assets from Merrimack

    CAMBRIDGE, Mass., Jan. 8, 2017 /PRNewswire/ — Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) (“Merrimack” or the “Company”) today announced that it has entered into a definitive asset purchase and sale agreement with Ipsen (Euronext: IPN; ADR: IPSEY) for a transaction valued at up to $1.025 billion, plus up to $33 million in …

April, 2015